Sense, antisense, and common sense

Journal of Nuclear Medicine

Volumn 42, Issue 11, 2001, Pages 1670-1672

  Urbain, J L C ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA;

CANCER RISK; CELL GROWTH; GENE CONTROL; GENE SEQUENCE; GENETIC TRANSCRIPTION; GROWTH REGULATION; HUMAN; NONHUMAN; NOTE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

DNA; DNA PROBES; NEOPLASMS; OLIGONUCLEOTIDES, ANTISENSE; ONCOGENES;

EID: 0035212145     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (30)

1. Synthesis of ribonucleosides and diribonucleoside phosphates containing 2-chloroethylamine and nitrogen mustard residues
2. Specific regulation of gene expression by antisense, sense and antigene nucleic acids
3. Inhibition of flower pigmentation by antisense CHS genes: Promoter and minimal sequence requirements for the antisense effect
4. Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxynucleotide
5. Phosphorothioate analogs of oligodeoxynucleotides: Inhibitors of replication and cytopathic effects of human immunodeficiency virus
6. Antisense oligonucleotides: An evolving technology for the modulation of gene expression in human disease
7. Prevention of coronary arteriosclerosis by antisense cdk2 kinase oligonucleotide
8. Ex vivo gene therapy prevents chronic graft vascular disease in cardiac allografts
9. A placebo controlled trial of ICAM-1 antisense oligonucleotide in the treatment of Crohn's disease
10. Pharmacokinetics and tolerability of intravenous trecovirsen (GEM 91), an antisense phosphorothioate oligonucleotide, in HIV-positive subjects
11. Formivirsen
12. Noninvasive imaging of c-myc oncogene messenger RNA with indium-11-antisense probes in a mammary tumor-bearing mouse model
13. Scintigraphic imaging of oncogenes with antisense probes: Does it make sense?
14. Antisense oligonucleotides as therapeutic agents: Is the bullet really magical?
15. Making sense out of anti-sense: Challenging of imaging gene translation with radiolabeled oligonucleotides
16. Antisense and nuclear medicine
17. General method to label antisense oligonucleotides with radioactive halogens for pharmacological and imaging studies
18. 99mTc-labeled antisense DNA
19. Specificity of antisense oligonucleotides in vivo
20. Theoretical design of antisense RNA structures substantially improves annealing kinetics and efficacy in human cells
21. A potential role for antisense oligonucleotide analogues in the development of oncogene targeted cancer chemotherapy
22. Pharmacokinetics, biodistribution and stability of oligodeoxynucleotide phosphorothioate in mice
23. Cellular uptake of oligodeoxynucleotide phosphorothioates and their analogs
24. In vivo antisense imaging
25. Antisense imaging of gene expression in the train in vivo
26. The delivery of antisense therapeutics
27. Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable a ninolipids: Formation of novel small multilamellar vesicle structures
28. Phosphodiester and phosphorothioate oligonucleotide condensation and preparation of antisense nanoparticles
29. Inhibition of breast cancer growth in vivo by antiangiogenesis gene therapy with adenovirus-mediated antisense-VEGF
30. Reporter genes and imagene